triazolam has been researched along with Alzheimer Disease in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In in vitro experiments, amiridine in concentration of 100, 200, and 300 microM restored disturbed structure of microtubules assembled from tubulin and microtubule-associated proteins isolated from the brain of patients with Alzheimer disease." | 7.74 | Effect of tacrine, amiridine, akatinol memantine, and triazolam on phosphorylation, structure, and assembly of microtubules from brain microtubular proteins in Alzheimer diseases. ( Burbaeva, GSh; Shevtsov, PN; Shevtsova, EF, 2008) |
| "In in vitro experiments, amiridine in concentration of 100, 200, and 300 microM restored disturbed structure of microtubules assembled from tubulin and microtubule-associated proteins isolated from the brain of patients with Alzheimer disease." | 3.74 | Effect of tacrine, amiridine, akatinol memantine, and triazolam on phosphorylation, structure, and assembly of microtubules from brain microtubular proteins in Alzheimer diseases. ( Burbaeva, GSh; Shevtsov, PN; Shevtsova, EF, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shevtsov, PN | 1 |
| Shevtsova, EF | 1 |
| Burbaeva, GSh | 1 |
| McCarten, JR | 1 |
| Kovera, C | 1 |
| Maddox, MK | 1 |
| Cleary, JP | 1 |
1 trial available for triazolam and Alzheimer Disease
| Article | Year |
|---|---|
Triazolam in Alzheimer's disease: pilot study on sleep and memory effects.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Humans; Hypnotics and Sedatives; Male; Memory; Middle Ag | 1995 |
1 other study available for triazolam and Alzheimer Disease
| Article | Year |
|---|---|
Effect of tacrine, amiridine, akatinol memantine, and triazolam on phosphorylation, structure, and assembly of microtubules from brain microtubular proteins in Alzheimer diseases.
Topics: Alzheimer Disease; Aminoquinolines; Brain; Dopamine Agents; GABA Modulators; Humans; Memantine; Micr | 2008 |